XML 14 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Cash, Cash Equivalents and Short-Term Investments
9 Months Ended
Aug. 28, 2020
Cash, Cash Equivalents, and Short-term Investments [Abstract]  
CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTSCash equivalents consist of highly liquid marketable debt securities with remaining maturities of three months or less at the date of purchase. We classify our investments in marketable debt securities as “available-for-sale.” We carry these investments at fair value, based on quoted market prices or other readily available market information. Unrealized gains and losses, net of taxes, are included in accumulated other comprehensive income, which is reflected as a separate component of stockholders’ equity in our condensed consolidated balance sheets. Gains and losses are determined using the specific identification method and recognized when realized in our condensed consolidated statements of income. When we have determined that an other-than-temporary decline in fair value has occurred, the amount of the decline that is related to a credit loss is recognized in income.
Cash, cash equivalents and short-term investments consisted of the following as of August 28, 2020:
(in millions)Amortized
Cost
Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
Current assets:    
Cash$740 $ $ $740 
Cash equivalents:
Corporate debt securities5   5 
Money market mutual funds2,937   2,937 
Time deposits85   85 
Total cash equivalents3,027   3,027 
Total cash and cash equivalents3,767   3,767 
Short-term fixed income securities:
Asset-backed securities89   89 
Corporate debt securities1,384 11  1,395 
Municipal securities13   13 
Total short-term investments1,486 11  1,497 
Total cash, cash equivalents and short-term investments$5,253 $11 $ $5,264 
Cash, cash equivalents and short-term investments consisted of the following as of November 29, 2019:
(in millions)Amortized
Cost
Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
Current assets:    
Cash$467 $ $ $467 
Cash equivalents:  
Corporate debt securities46   46 
Money market mutual funds2,049   2,049 
Time deposits88   88 
Total cash equivalents2,183   2,183 
Total cash and cash equivalents2,650   2,650 
Short-term fixed income securities: 
Asset-backed securities89   89 
Corporate debt securities1,408 4  1,412 
Municipal securities18   18 
U.S. Treasury securities8   8 
Total short-term investments1,523 4  1,527 
Total cash, cash equivalents and short-term investments$4,173 $4 $ $4,177 

We had immaterial gross unrealized losses related to our available-for-sale securities as of August 28, 2020 and November 29, 2019. The following table summarizes the fair value of our available-for-sale securities that have been in a continuous unrealized loss position as of August 28, 2020 and November 29, 2019:
(in millions)20202019
 Less Than
Twelve Months
More Than
Twelve Months
Less Than
Twelve Months
More Than
Twelve Months
Corporate debt securities$155 $ $235 $44 
Asset-backed securities10  7 7 
Municipal securities1  3  
Total$166 $ $245 $51 
There were 70 securities and 115 securities in an unrealized loss position for less than twelve months at August 28, 2020 and November 29, 2019, respectively. There were no securities in an unrealized loss position for more than twelve months at August 28, 2020, and 38 securities in an unrealized loss position for more than twelve months at November 29, 2019.
The following table summarizes the cost and estimated fair value of short-term fixed income securities classified as short-term investments based on stated effective maturities as of August 28, 2020:
(in millions)Amortized
Cost
Estimated
Fair Value
Due within one year$890 $894 
Due between one and two years393 398 
Due between two and three years176 178 
Due after three years27 27 
Total$1,486 $1,497 
We review our debt securities classified as short-term investments on a regular basis to evaluate whether or not any security has experienced an other-than-temporary decline in fair value. We consider factors such as the length of time and extent to which the market value has been less than the cost, the financial condition and near-term prospects of the issuer and our intent to sell, or whether it is more likely than not we will be required to sell the investment before recovery of the investment’s amortized cost basis. If we believe that an other-than-temporary decline exists in one of these securities, we write down these investments to fair value. The portion of the write-down related to credit loss would be recorded to other income (expense), net in our condensed consolidated statements of income. Any portion not related to credit loss would be recorded to accumulated other comprehensive income, which is reflected as a separate component of stockholders’ equity in our condensed consolidated balance sheets. During the nine months ended August 28, 2020 and August 30, 2019, we did not consider any of our investments to be other-than-temporarily impaired.